Literature DB >> 11275643

Human placenta as a source of neuroendocrine factors.

F M Reis1, P Florio, L Cobellis, S Luisi, F M Severi, C Bocchi, E Picciolini, G Centini, F Petraglia.   

Abstract

Progress in the understanding of the physiological and pathological functions of the placenta introduced the concept that the placenta is a neuroendocrine organ, since it shows local production and release of substances analog to neurohormones. These products act as endocrine, paracrine and autocrine factors to control the secretion of other regulatory molecules, including the pituitary hormones of both mother and fetus and their placental counterparts. Furthermore, they may play a role in the regulation of maternal and fetal physiology during pregnancy, ranging from the control of placental anchoring to fetal growth and maturation, fine regulation of uterine blood flow and/or initiation of labor. All this evidence underlines the decisive contribution of the placenta to all phases of gestation, through a range of substances largely exceeding the classically known sex steroids and chorionic gonadotropin, throughout normal pregnancy as well as in the presence of gestational diseases. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275643     DOI: 10.1159/000047083

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  8 in total

Review 1.  Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family.

Authors:  Pasquale Florio; Filiberto M Severi; Pasquapina Ciarmela; Giovina Fiore; Giulia Calonaci; Angelica Merola; Claudio De Felice; Marco Palumbo; Felice Petraglia
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming.

Authors:  Stefanie L Bronson; Tracy L Bale
Journal:  Neuropsychopharmacology       Date:  2015-08-07       Impact factor: 7.853

Review 3.  Developmental origins of inflammatory and immune diseases.

Authors:  Ting Chen; Han-Xiao Liu; Hui-Yi Yan; Dong-Mei Wu; Jie Ping
Journal:  Mol Hum Reprod       Date:  2016-05-25       Impact factor: 4.025

4.  Limited Impact of Fetal Sex and Maternal Body Mass Index on Fetal and Maternal Insulin Resistance and Lipid Metabolism: Findings from the PEARs Study.

Authors:  Anthony R Rafferty; Aisling A Geraghty; Maria A Kennelly; Eileen C O'Brien; Reshma Merin Reji; John Mehegan; Ricardo Segurado; Thomas Smith; Orla Maguire; Martina Cronin; Fionnuala M McAuliffe
Journal:  Reprod Sci       Date:  2020-01-10       Impact factor: 3.060

5.  Myometrial contractility influences oxytocin receptor (OXTR) expression in term trophoblast cells obtained from the maternal surface of the human placenta.

Authors:  Dariusz Szukiewicz; Anna Bilska; Tarun Kumar Mittal; Aleksandra Stangret; Jaroslaw Wejman; Grzegorz Szewczyk; Michal Pyzlak; Jacek Zamlynski
Journal:  BMC Pregnancy Childbirth       Date:  2015-09-16       Impact factor: 3.007

6.  Metalloprotease dependent release of placenta derived fractalkine.

Authors:  Monika Siwetz; Astrid Blaschitz; Julia Kremshofer; Jelena Bilic; Gernot Desoye; Berthold Huppertz; Martin Gauster
Journal:  Mediators Inflamm       Date:  2014-03-13       Impact factor: 4.711

Review 7.  Measurement of androgen and estrogen concentrations in cord blood: accuracy, biological interpretation, and applications to understanding human behavioral development.

Authors:  Lauren P Hollier; Jeffrey A Keelan; Martha Hickey; Murray T Maybery; Andrew J O Whitehouse
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-02       Impact factor: 5.555

8.  Placenta - Worth Trying? Human Maternal Placentophagia: Possible Benefit and Potential Risks.

Authors:  Sophia K Johnson; Jana Pastuschek; Jürgen Rödel; Udo R Markert; Tanja Groten
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-09-14       Impact factor: 2.915

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.